Impact of in Utero and Breastfeeding Exposure to Tenofovir on Renal Function in HIV-exposed Uninfected Children
NCT04070482 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2019-08-29
Summary
The goal of this project is to determine whether and how in utero exposure to Tenofovir affects renal function in HIV-exposed uninfected infants
Conditions
- Renal Injury
Interventions
- OTHER
-
Tenofovir exposure in utero and during breastfeeding
Exposed in utero and during breastfeeding to Tenofovir-containing antiretroviral drugs
Sponsors & Collaborators
-
Institut National de la Santé Et de la Recherche Médicale, France
collaborator OTHER_GOV -
University of Yaounde 1
lead OTHER
Principal Investigators
-
Gabriel L Ekali, MD,MH · University of Yaounde 1
Eligibility
- Max Age
- 1 Year
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2017-10-01
- Primary Completion
- 2019-04-30
- Completion
- 2019-12-31
Countries
- Cameroon
Study Locations
More Related Trials
-
Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women
NCT03902418 ·Status: COMPLETED
-
Infant Peri-Exposure Prophylaxis to Prevent HIV-1 Transmission by Breastfeeding: Mechanisms & Safety
NCT03519503 ·Status: COMPLETED
-
UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study
NCT06158126 ·Status: RECRUITING ·Phase: PHASE4
-
Pregnancy, Anti-integrase and Lymphocyte Repertoire of the Newborn
NCT04024150 ·Status: COMPLETED
-
The Kabeho Study: Kigali Antiretroviral and Breastfeeding Assessment for the Elimination of HIV
NCT02295800 ·Status: COMPLETED
-
National Cohort of Children Born to HIV-positive Mothers
NCT03306251 ·Status: UNKNOWN
-
Tenofovir/Emtricitabine for PMTCT in Africa and Asia (ANRS 12109 TEmAA)
NCT00334256 ·Status: COMPLETED ·Phase: PHASE2
-
Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP
NCT00204308 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of 1592U89 in HIV-Infected Children
NCT00002197 ·Status: COMPLETED ·Phase: NA
-
HIV Diagnosis and Treatment at Birth for Newborn With High Risk HIV Exposure
NCT03642704 ·Status: COMPLETED ·Phase: PHASE4
-
Surveillance Monitoring for ART Toxicities Study in HIV Uninfected Children Born to HIV Infected Women
NCT01310023 ·Status: COMPLETED
-
PrEP in Breastfeeding Study
NCT02776748 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Therapeutic Drug Monitoring to oPtimize ANtiretroviral regimeNs in HIV-infected Women Who wAnt to Breastfeed
NCT05642481 ·Status: COMPLETED
-
Antiretroviral Adherence Evaluation in HIV Pregnant and Postpartum Women
NCT01621347 ·Status: COMPLETED
-
Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries
NCT01061151 ·Status: COMPLETED ·Phase: PHASE3
-
Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission
NCT00115648 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Function of Infants With HIV
NCT00073229 ·Status: COMPLETED
-
Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
NCT02738502 ·Status: COMPLETED ·Phase: PHASE2
-
Chinese Network of Pediatric Antiretroviral Therapy
NCT01210924 ·Status: COMPLETED
-
Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People.
NCT00404989 ·Status: RECRUITING
-
Cohort of HIV-infected Children
NCT03235258 ·Status: COMPLETED
-
Evaluating the Pharmacokinetics, Feasibility, Acceptability, and Safety of Oral Pre-Exposure Prophylaxis for HIV Prevention During Pregnancy and Postpartum
NCT03386578 ·Status: COMPLETED ·Phase: PHASE2
-
When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)
NCT00234091 ·Status: COMPLETED ·Phase: PHASE3
-
Prospective Observational Cohort Study on Mother to Child Transmission HIV1/HIV2 and Prevention
NCT03235310 ·Status: UNKNOWN
-
Viral and Antiretroviral Dynamics in HIV-1 Mother-to-Child Transmission Fluids
NCT03284645 ·Status: COMPLETED